FR2818907B1 - USE OF BRIVUDINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION - Google Patents

USE OF BRIVUDINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION

Info

Publication number
FR2818907B1
FR2818907B1 FR0108596A FR0108596A FR2818907B1 FR 2818907 B1 FR2818907 B1 FR 2818907B1 FR 0108596 A FR0108596 A FR 0108596A FR 0108596 A FR0108596 A FR 0108596A FR 2818907 B1 FR2818907 B1 FR 2818907B1
Authority
FR
France
Prior art keywords
brivudine
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0108596A
Other languages
French (fr)
Other versions
FR2818907A1 (en
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlin Chemie AG
Original Assignee
Berlin Chemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie AG filed Critical Berlin Chemie AG
Publication of FR2818907A1 publication Critical patent/FR2818907A1/en
Application granted granted Critical
Publication of FR2818907B1 publication Critical patent/FR2818907B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
FR0108596A 2001-01-03 2001-06-29 USE OF BRIVUDINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION Expired - Lifetime FR2818907B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (en) 2001-01-03 2001-01-03 PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (2)

Publication Number Publication Date
FR2818907A1 FR2818907A1 (en) 2002-07-05
FR2818907B1 true FR2818907B1 (en) 2006-05-26

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0108596A Expired - Lifetime FR2818907B1 (en) 2001-01-03 2001-06-29 USE OF BRIVUDINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION

Country Status (20)

Country Link
AT (1) AT6141U1 (en)
BE (1) BE1014522A5 (en)
CH (1) CH695662A5 (en)
CZ (1) CZ20012464A3 (en)
DK (1) DK177084B1 (en)
ES (1) ES2192456B1 (en)
FI (1) FI20011446A (en)
FR (1) FR2818907B1 (en)
GB (1) GB2370771A (en)
GR (1) GR1004012B (en)
HR (1) HRPK20010345B3 (en)
HU (1) HUP0102816A3 (en)
IE (1) IE20010413A1 (en)
IT (1) ITMI20010009A1 (en)
NL (1) NL1018431C2 (en)
PL (1) PL348480A1 (en)
PT (1) PT102642B (en)
SE (1) SE0102309L (en)
SK (1) SK287043B6 (en)
UA (1) UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (en) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) * 1983-10-31 1987-06-03 Anna Gioia Stendardi THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application

Also Published As

Publication number Publication date
ITMI20010009A0 (en) 2001-01-03
ES2192456A1 (en) 2003-10-01
PT102642A (en) 2002-07-31
PL348480A1 (en) 2002-07-15
CZ20012464A3 (en) 2002-08-14
DK177084B1 (en) 2011-07-11
GB2370771A (en) 2002-07-10
FI20011446A (en) 2002-07-04
HRPK20010345B3 (en) 2005-02-28
AT6141U1 (en) 2003-05-26
DK200101019A (en) 2002-07-04
CH695662A5 (en) 2006-07-31
PT102642B (en) 2003-06-30
SE0102309L (en) 2002-07-04
IE20010413A1 (en) 2003-04-16
UA76402C2 (en) 2006-08-15
HUP0102816A2 (en) 2002-10-28
FI20011446A0 (en) 2001-07-03
GB0110682D0 (en) 2001-06-20
HRP20010345A2 (en) 2003-08-31
FR2818907A1 (en) 2002-07-05
SE0102309D0 (en) 2001-06-28
SK9572001A3 (en) 2003-03-04
GR20010100322A (en) 2002-10-08
HUP0102816A3 (en) 2005-01-28
ES2192456B1 (en) 2005-02-01
SK287043B6 (en) 2009-10-07
HU0102816D0 (en) 2001-09-28
GR1004012B (en) 2002-11-01
ITMI20010009A1 (en) 2002-07-03
BE1014522A5 (en) 2003-12-02
NL1018431C2 (en) 2002-07-05

Similar Documents

Publication Publication Date Title
DZ2494A1 (en) Pharmaceutical composition of omeprazole.
DZ2405A1 (en) Use of central cannabinoid receptor antagonists for the preparation of medicaments
PT1066027E (en) PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
FR2775187B1 (en) USE OF EPOTHILONE B FOR THE MANUFACTURE OF AN ANTIPROLIFERATIVE PHARMACEUTICAL PREPARATION AND A COMPOSITION COMPRISING EPOTHILONE B AS AN IN VIVO ANTIPROLIFERATIVE AGENT
DE69731674D1 (en) Silencieux d'aspiration pour compresseur
FR2829142B1 (en) FILMOGENEOUS COMPOSITION OF HETEROXYLANE FOR THE MANUFACTURE OF CAPSULES THUS OBTAINED
FR2817750B1 (en) DRONEDARONE PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION
MA26531A1 (en) PHARMACEUTICAL COMPOSITION
FR2831483B1 (en) MULTI-LAYER PEELABLE LID OR LID MATERIALS
FR2818907B1 (en) USE OF BRIVUDINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
FR2811998B1 (en) USE OF HETEROXYLANES FOR THE PREPARATION OF FILM-FORMING COMPOSITIONS
FR2770841B1 (en) CONCENTRATED HYDROALCOHOLIC FLUID ALKYLAMIDOPROPYLBETAN COMPOSITIONS OF COPRAH OR PALMIST
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
FR2700328B1 (en) Compositions for cement and cements obtained from these compositions.
FR2792833B1 (en) USE OF N-ANISOYL-GAMMA-AMINOBUTYRIC ACID OR P-ANISIC ACID FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
FR2821270B1 (en) USE OF FREE NICOTINE FOR THE MANUFACTURE OF AN ANTI-CELLULITIC COMPOSITION
FR2723317B1 (en) USE OF NEUROTENSIN ANTAGONISTS FOR THE PREPARATION OF DIURETIC DRUGS
FR2828403B1 (en) USE OF HLA CLASS 1 SOLUBLE MOLECULES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR INHIBITING ANGIOGENESIS
FR2758460B1 (en) USE OF ADRENERGIC BETA-3 RECEPTOR AGONISTS FOR THE PREPARATION OF HEALING MEDICINAL PRODUCTS
ITMI20011284A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERPHOSPHATEMIA
FR2803901B1 (en) UNIVERSAL PROFILE FOR THE REALIZATION OF MODULAR CONSTRUCTION
FR2852242B1 (en) USE OF OLIGOGALACTURONIDES IN COSMETICS OR FOR THE PREPARATION OF A DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION
FR2746012B1 (en) USE OF TIAMULIN FOR THE PREPARATION OF A MEDICINAL PRODUCT AS A CANCER MULTI-CHEMICAL RESISTANCE AGENT
FR2862537B1 (en) USE OF FEPRADINOL FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ROSACEA
FR2825634B1 (en) DISINFECTANT COMPOSITION AND ADDITIVE SOLUTION FOR PREPARING SUCH A COMPOSITION

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 20